Percutaneous closure of postmyocardial infarction ventricular septal defect with the CardioSEAL septal occluder
1Division of Cardiology, Department of Medicine, Lahey Clinic Medical Center, Burlington, Massachusetts 01805, USA.
Insights
Successful closure of postinfarction septal defects was achieved using the CardioSEAL septal occluder implant. This device offers a promising alternative for high-risk patients with ventricular septal rupture.
Area of Science:
- Cardiology
- Medical Devices
- Interventional Cardiology
Background:
- Postinfarction ventricular septal rupture is a rare but devastating complication of myocardial infarction.
- It is associated with high mortality rates, with limited treatment options.
Observation:
- A high-surgical-risk patient presented with a postinfarct septal defect.
- The patient's condition posed significant challenges for traditional surgical intervention.
Findings:
- The CardioSEAL septal occluder implant was successfully deployed in the patient.
- This transcatheter device effectively closed the ventricular septal defect.
Implications:
- The CardioSEAL device represents a viable therapeutic option for managing postinfarct septal defects.
- This approach may improve outcomes for high-risk surgical patients, reducing morbidity and mortality.
Abstract:
Postinfarction ventricular septal rupture carries a poor prognosis with medical or surgical treatment. We report on successful deployment of CardioSEAL septal occluder implant for postinfarct septal defect in a high-surgical-risk patient.
